1. Abrass CK, Mcvay J, Glassock RJ. Evaluation of homologous and isologous passiveHeymann nephritis: influence on endogenous antibody production. J Immunol 1983;130:195-202.
  2. Ang C, Savige J, Dawborn J et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transpl 1998; 13:935-39
  3. Antignac C, Hinglais N, Gubler MC, Gagnadoux MF, Broyer M, Habib R. De novo membranous glomerulonephritis in renal allografts in children. Clin Nephrol 1988;30:1-7.
  4. Asal NR, Cleveland HL, Kaufman C, et al. Hydrocarbon exposure and chronic renal disease. Int Arch Occup Environ Health 1996; 68: 229-35. 
  5. Askergren A, Allgén LG, Karlsson C, Lundberg I, Nyberg E. Studies on kidney function in subjects exposed to organic solvents. I. Excretion of albumin and b-2-microglobulinin the urine. Acta Med Scand 1981; 209: 479-483.
  6. Askergren A. Studies on kidney function in subjects exposed to organic solvents. III.Excretion of cells in the urine. Acta Med Scand 1981; 210:103-106.
  7. Bailey RR, Simpson IJ, Lynn KL et al. Goodpasture´s syndrome with normal renal function. Clin Nephrol 1981; 15: 211-215.
  8. Banks KL, Henson JB. Immunologically mediated glomerulitis of horses. II.Antiglomerular basement membrane antibody and other mechanisms in spontaneousdisease. Lab Invest 1972; 26: 708-715.
  9. Barabas AZ, Lannigan R. Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephriis.Brit J Exp Path 1974; 55: 47-55
  10. Batsford SR, Takamiya H, Vogt A. A model of in situ immune complex glomerulonephritis in the rat employing cationized ferritin. Clin Nephrol 1980; 14: 211-16.
  11. Bell GM, Doig A, Thomson D, Anderton JL, Robson JS. End-stage renal failure associated with occupational exposure to organic solvents. Proc EDTA-ER, 1985; 22: 725-729.
  12. Bell GM, Gordon ACH, Lee P, et al. Proliferative glomerulonephritis and exposure to organic solvents. Nephron 1985; 40: 161-5.
  13. Bernard A, Lauwerys R, Mahieu P, Foidart JM.Antibasement-membrane antibodies in the serum of healthy subjects. N Engl J Med 1986; 314: 1456-1457.
  14. Bertolatus JA. Maleic vinyl ether anhydride nephropathy: altered glomerular permeabilitydue to an immunomodulating agent. Clin Immunol Immunopathol 1988; 49:6-18.
  15. Bohle A, Grund KE, Mackensen S, Tolon M. Correlations between renal interstitium and level of serum creatinine. Morphometric investigations of biopsies in perimembranous glomerulonephritis. Virchows Arch A Path Anat Histol 1977;373:15-22.
  16. Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B
    The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr 1981; 59: 1043-1051.
  17. Border WA, Ward HJ, Kamil ES, Cohen AH. Inductionof membranous nephropathy in rabbits by administration of an exogenous cationic antigen. Demonstration of a pathogenic role for electrical charge. J Clin Invest 1982; 69: 451-61.
  18. Bremner DA, Tange JD. Renal and neoplastic lesions after injection of N-N´-diacetylbenzidine. Arch Pathol 1966; 81: 146-51.
  19. Cameron JS. Glomerulonephritis: current problems and understanding. J Lab Clin Med 1982;99:755-787.
  20. Carrol lN, Crock GW, Funder CC, Green CR, Ham KN, Tange JD. Glomerular epithelial cell lesions induced by N,N´-diacetylbenzidine. Lab Invest 1974; 31: 239-245.
  21. Condie LW, Smallwood CL, Laurie RD. Comparative renal and hepatotoxicity of halomethanes: bromodichloromethane, bromoform, chloroform, dibromochloromethane and methylene chloride. Drug Chem Toxicol 1983; 6:563-78.
  22. Couser WG, Wallace A, Monaco AP, Lewis EJ.Succesful renal transplantation in patients with circulating antibody to glomerular basement membrane: Report of two cases. Clin Nephrol 1973;1: 381-388.
  23. CouserWG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein MM. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest1978; 62: 1275-87.
  24. CouserWG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int 1980; 17: 1-13.
  25. Couser WG. Pathogenesis of glomerulonephritis. Kidney Int 1993; 44(Suppl 42):S19-S26.
  26. Couser WG. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 1998; 13(suppl 1): 10-15.
  27. Couser WG. Glomerulonephritis. Lancet 1999; 353: 1509-1515
  28. DeBroe ME, D´Haese PC, Nuyts GD, Elseviers MM. Occupational renal diseases. Curr Opinion Nephrol Hypertens 1996; 5: 114-121.
  29. Dixon FJ, Feldhan JD, Vasquez JJ.Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 1961;113: 899-920.
  30. Dixon FJ. The pathogenesis of glomerulonephritis . Am J Med 1968; 44: 493-498.
  31. Dunn TB, Morris HP,Wagner BP. Lipemia and glomerular lesions in rats fed diets containing N-N´-diacetyl-and 4, 4-4´, 4´-tetramethylbenzidine. Proc Soc Exp Biol Med 1956; 91: 105-7.
  32. Easley JR, Holland JM, Gipson LC, Whitaker MJ. Renal toxicity of middle distillates of shale oil and petroleum in mice. Toxicol Appl Pharmacol 1982; 65: 84-91.
  33. ErwinDT, Donadio JV, Holley KE. The clinical course of idiopathic membranousnephropathy. Mayo Clinic Proc 1973; 48: 697-712.
  34. FabreR, Truhaut R, Laham S. Recherches toxicologiques sur les solvants deremplacement du benzène. IV. – Étude des xylènes (1). Arch Mal Profess 1960; 21: 301-313.
  35. FeenstraK, van der Lee R, Greben HA et al. Experimental glomerulonephritis in the ratinduced by antibodies directed against tubular antigens. I. The natural history:a histologic and immunohistologic study at the light microscopeic and theultrastructural level. Lab Invest 1975; 32: 235-242
  36. Finn R, Fennerty AG, Ahmad R. Hydrocarbon exposure andglomerulonephritis. Clin Nephrol 1980; 14: 173-5.
  37. FleurenGJ, Grond J, Hoedemaeker PJ.The pathogenetic role of free-circulating antibodyin autologous immune complex glomerulonephritis. Clin Exp Immunol 1980;41: 205-217.
  38. Franchini I, Lucertini S, Chiesa E, Mutti A. Organic solvent exposure andchronic glomerulonephritis: a case-control study. X. Medichem 1982;14-16: 169-75.
  39. Germuth FG. A comparative histologic andimmunologic study in rabbit of induced hypersensitivity of the serum sickness type. J Exp Med 1953; 97: 257-282.
  40. GormlyAA, Smith PS, Seymour AE, Clarkson AR, Woodroffe AJ. IgA glomerular depositsin experimental cirrhosis. Am J Pathol 1981; 104: 50-54
  41. Gregorini G, Ferioli A, Donato F, Tira P, Morassi L, Tardanico R, Lancini L, Maiorca R. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol 1993; 336: 435-40.
  42. Hammer DK, Dixon FJ. Experimental glomerulonephritis. II. Immunologic events in the pathogenesis of nephrotoxic serum nephritis. J Exp Med 1963; 117:1019-1034.
  43. Harman JW. Chronic glomerulonephritis and the nephrotic syndrome induced in rats with N,N´-diacetylbenzidine. J Pathol 1971; 104: 119-128
  44. Harrington JM, Whitby H, Gray CN, Reid FJ, Aw TC, Waterhouse JA. Renal disease and occupationbal exposure to organic solvents: a case referent approach. Brit J Industr Med 1989; 46: 643-50.
  45. Harrison DJ, Thomson D, MacDonald MK. Membranous glomerulonephritis. J Clin Pathol 1986; 39: 167-71.
  46. Hashimoto DM, Kelsey KT, Seitz T, Feldman HA, Yakes B, Christiani DC. The presence of urinary cellular sediment and albuminuria in newspaper pressworkers exposed to solvents. J Occupat Med 1991; 33: 517-526.
  47. Helin H, Pasternack A, Hakala T, Penttinen K, Wager O. Glomerular electron-dense deposits and circulating immune complexes in patients with malignant tumours. Clin Nephrol 1980; 14: 23-30.
  48. HeymannW, Hackel DB, Harwood S. et al. Production of nephrotic syndrome in rats by Freunds adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 1959;100: 660-664.
  49. Heymann W, Hunter JLP, Hackel DB. Experimental auto-immune nephrosis in rats: III. J Immunol 1962; 88: 135-141.
  50. Hoorntje SJ, Kallenberg CGM, Weening JJ, Donker AJM, The TH, Hoedemaeker PJ. Immune-complex glomerulopathy in patients treated with captopril. Lancet 1980; 1:1212-1215
  51. Hotz P, Pilliod J, Söderström D, Rey F, Boillat MA, Savolainen H. Relation between renal function tests and a retrospective organic solvent exposure score. BritJ Industr Med 1989; 46: 815-819.
  52. Hotz P, Pilliod J, Bernard A, Rey F, Boillat MA. Erythrocytes glomérulaires, albuminurie, glycosaminoglycanes et exposition aux hydrocarbures. Schweiz Med Wschr 1990a; 120: 999-1004.
  53. Hotz P, Pilliod J, Bernard A, Berode M, Rey F, Mazzocato C, Guillemin M, Boillat M-A. Hydrocarbon exposure, hypertension and kidney function tests. Int Arch Occup Environ Health 1990b; 62: 501-508.
  54. Hotz P, Pilliod J, Berode M, Rey F, Boillat MA. Glycosaminoglycans, albuminuria and hydrocarbon exposure. Nephron 1991; 58: 184-191.
  55. Hotz P, Thielemans N, Bernard A, Gutzwiller F, Lauwerys R. Serum laminin,hydrocarbon exposure, and glomerular damage. Brit J Industr Med 1993; 50:1104-1110.
  56. Hotz P. Occupational hydrocarbon exposure and chronic nephropathy. Toxicology 1994;90:163-283
  57. Huber W, Ritz E, Fliser D. Does occupational exposure to toxins increase albuminexcretion rate? Kidney Int 1998; 54: 303-304.
  58. Huber W, Conradt C, Dangl C et al. Organische Lösemittel und chronische Glomerulonephritis.  Nieren Hochdruckkrankheiten 2000;29:.41-53.
  59. Hultberg B, Ravnskov U. The excretion of N-acetyl-b-glucosaminidase in glomerulonephritis. Clin Nephrol 1981; 15: 33-38.
  60. Johansson BG, Ravnskov U. The serum level and urinary excretion of a2-microglobulin,b2-microglobulin and lysozyme in renal disease. Scand J Urol Nephrol  1972; 6: 249-256.
  61. Klavis G, Drommer W. Goodpasture-syndrom und Benzineinwirkung. Arch Toxicol 1970;26: 40-55.
  62. Lagrue G, Kamalodine T, Hirbec G, Bernaudin JF, Guerrero J, Zhepova. Rôle de l´inhalation de substances toxiques dans la genèse des glomérulonéphrites. Nouv Presse Med 1977; 6: 3609-13.
  63. Larsen S. Glomerular immune deposits in kidneys from patients with no clinical or lightmicroscopic evidence of glomerulonephritis. Acta Path Microbiol Scand (SectA) 1979; 87: 313-319.
  64. Lee HS, Koh HI. Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol 1993; 39: 7-16
  65. Lerner RA, Dixon FJ. Spontaneous glomerulonephritis in sheep. Lab Invest 1966;1279-1289.
  66. Lerner RA, Dixon FJ, Lee S. Spontaneous glomerulonephritis in sheep. II. Studies on natural history, occurrence in other species, and pathogenesis. Am J Pathol 1968; 53: 501-512.
  67. MarkhamRV, Sutherland JC, Mardiney MR. The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest  1973;29: 111-120.
  68. Miettinen A. Nephritogenic antibodies against kidney brush border glycoproteins in rabbits injected with Freund´s adjuvant.  Lab Invest 1982; 47:67-75.
  69. Mosinger M, Fiorentini H. Intoxication expérimentale par le trichloréthyléne. Annal Med Leg Crim Pol Scient Toxicol 1958; 38: 319-324.
  70. Mutti A, Alinovi R, Bergamaschi E, et al. Nephropathies and exposure to perchloroethylene in dry-cleaners. Lancet 1992; 340: 189-193.
  71. Nakajima H. Tubulo-interstitial nephritis in guinea pigs sensitized to 2,4-dinitrochlorobenzen. Osaka City Med J. 1981;27:93-100.
  72. Nakajima H, Nishiwaki S, Shimada I. Induction of anti-tubular- and anti-glomerular-basement-membrane antibodies in guinea pigs sensitized to 2,4-dinitrochlorobenzen with reference to tubulo-interstitial and glomerularnephritis. Osaka City Med J 1982; 28: 59-65.
  73. Navas-Palacios JJ, Usera-Sárraga G, Gil-Martin R. Pathology of the kidney in“toxic oil epidemic syndrome”. J Toxicol Environ Health 1984; 13:1-18.
  74. NealeTJ, Woodroffe AJ, Wilson CB. Spontaneous glomerulonephritis in rabbits: role of a glomerular capillary antigen. Kidney Internat  1984; 26: 701-711
  75. Nelson NA, Robins TG, Port FK. Solvent nephrotoxicity in humans and experimental animals. Am J Nephrol 1990;10: 10-20.
  76. Nuyts GD, van Vlem E, Thys J, et al. New occupational risk factors for chronic renal failure. Lancet 1995; 346: 7-11.
  77. OgawaM, Mori T, Mori Y, et al. Study on chronic renal injuries induced by carbontetrachloride: selective inhibition of nephrotoxicity by irradiation. Nephron 1992; 60: 68-73.
  78. Pai P, Stevenson A, Mason H, Bell GM. Occupational hydrocarbon exposure and nephrotoxicity: a cohort study and literature review. Postgrad Med J 1998; 74: 225-228.
  79. Pascal RR, Iannaccone PM, Rollwagen FM, Harding TA, Bennett SJ. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients. Cancer Res 1976;36: 43-47
  80. Poon-King T, Mohammed I, Cox R, Potter EV, Simon NM, Siegel AC, Earle DP . Recurrent epidemic nephritis in South Trinidad. N Engl J Med 1967; 277: 728-733.
  81. Porro A, Lomonte C, Coratelli P, Passavanti G, Ferri GM, Assennato G. Chronic glomerulonephritis and exposurte to solvents: a case-referent study. Brit J Industr Med 1992; 49: 738-42.
  82. RamzyMH, Cameron JS, Turner DR, Neild GH, Ogg CS, Hicks J. The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 1981; 16: 13-19.
  83. Ravnskov U. Exposure to organic solvents – a missing link in acute poststreptococcal glomerulonephritis? Acta Med Scand1978; 203: 351-356
  84. Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents. A case-control study. Acta Med Scand 1979; 205: 575-9.
  85. Ravnskov U, Lundström S, Nordén Å. Hydrocarbon exposure and glomerulonephritis: Evidence from patients’ occupation. Lancet 1983; 2:1214-6.
  86. Ravnskov U. Possible mechanisms of hydrocarbon-associated glomerulonephritis. Clin Nephrol 1985; 23:294-298.
  87. Ravnskov U. Influence of hydrocarbon exposure on the course of glomerulonephritis. Nephron 1986; 42: 156-60
  88. Ravnskov U. Focal glomerular lesions in glomerulonephritis may be secondary to tubulo-interstitial damage. Am J KidneyDis 1988; 12: 250-251
  89. Ravnskov U. Non-systemic glomerulonephritis: Exposure to nephro- and immunotoxic chemicals is primary and predisposes to immunologic harassment. Med Hypotheses 1989;30: 115-122.
  90. Ravnskov U. The subepithelial formation of immune complexes in membranous glomerulonephritis may be harmless and secondary to allergic or toxic factors. Scand J Immunol 1998; 48: 469-474. 
  91. Ravnskov U. Glomerular,tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Brit J Clin Pharmacol 1999; 47: 203-210.
  92. Ravnskov U. Hydrocarbons may worsen renal function in glomerulonephritis: a meta-analysis of the case-control studies. Am J Indust Med 2000a; 37:599-606.
  93. Ravnskov U. Hydrocarbon exposure may cause glomerulonephritis and worsen renal function: evidence based on Hill´s criteria for causality. Q J Med 2000;93: 551-556
  94. Riemenschneider T, Mackensen-Haen S, Christ H, Bohle A. Correlation between endogenous creatinine clearance and relative interstitial volume of the renal cortex in patients with diffuse membranous glomerulonephritis having a normal serumcreatinine concentration. Lab Invest 1980; 43: 145-49
  95. Rodriguez-Iturbe B, Garcia R, Rubio L, Cuenca L, Treser G, Lange K. Epidemic glomerulonephritis in Maracaibo. Evidence for progression to chronicity. Clin Nephrol 1976; 5: 197-206.
  96. Rosenberg HG, Martinez PS, Vaccarezza AS, Martinez LV. Morphological findings in 70 kidneys of living donors for renal transplant. Pathol Res Pract 1990;186: 619-624.
  97. Roy AT, Brautbar N, Lee DBN. Hydrocarbons and renal failure. Nephron1991;58:385-92
  98. SakaguchiH, Dachs S, Mautner W, Grisham E, Churg J. Renal glomerular lesions after administration of carbon tetrachloride and ethionine. Lab Invest 1964; 13: 1418-1426.
  99. Savige JA, Baker C, Gallicchio M, Varigos G. Circulating anti-glomerular basement membrane antibodies in coeliac disease and epidermolysis bullosa acquisita. Aust N Z J Med 1991; 21: 867-70
  100. Seligson G, Lange K, Majeed HA, Deol H, Cronin W, Bovie R. Significance of endostreptosin antibody titers in poststreptococcal glomerulonephritis. Clin Nephrol 1985; 24: 69-75
  101. Sesso R, Stolley PD, Salgado N, Pereira AB, Ramos OL. Exposure to hydrocarbons and rapidly progressive glomeru­lonephritis. BrazilianJ Med Biol Res 1990; 23: 225-33.
  102. SteblayRW. Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund´s complete adjuvant. J Exp Med 1962; 116:253-272.
  103. Steblay RW, Rudofsky U. Spontaneous renal lesions and glomerular deposits of IgG and complement in guinea pigs. J Immunol 1971; 107: 1192-1196.
  104. Steenland NK, Thun MJ, Ferguson W, Port FK.  Occupational and other exposures associated with male end-stage renal disease. A case/control study. Am J Public Health 1990; 80: 153-9.
  105. Stengel B, Cénée S, Limasset J-C, et al. Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidemiol 1995; 24: 427-34.
  106. Stevenson A. Yaqoob M, Mason H, Pai P, Bell GM. Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents. Q J Med 1995;88: 23-28
  107. Suganuma T. Glomerular IgA deposits in an autopsy study. Nippon-Jinzo-Gakkai-Shi 1994; 36: 813-22.
  108. Sugisaki T, Klassen J, Andres GA et al. Passive transfer of Heymann nephritis with serum. Kidney Int 1973; 3: 66-73.
  109. Sutherland JC, Markham RV, Mardiney MR. Subclinical immune complexes in the glomeruliof kidneys postmortem. Am J Med 1974; 57: 536-541.
  110. Unanue ER, Dixon FJ. Experimental glomerulonephritis: immunological events and pathogenetic mechanismss. Adv Immunol 1967; 6: 1-90.
  111. Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in anon-selected autopsy series. Nephrol Dial Transplant 1989; 4:943-946.
  112. vander Laan G. Chronic glomerulonephritis and organic solvents. A case-control study. Int Arch Occup Environ Health 1980; 47: 1-8.
  113. Watson JI, Dixon FJ, Feldman JD. The effect of complete Freund´s adjuvant on rat kidneys. Lab Invest 1965; 14: 1559-1567.
  114. Wehrmann M, Bohle A, Bogenschütz O et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989; 31: 67-76.
  115. Viau C, Bernard A, Gueret F, Maldague P, Gengoux P, Lauwerys R. Isoparaffinic solvent-induced nephrotoxicity in the rat. Toxicology 1986; 38:227-240.
  116. Viau C, Bernard A, Lauwerys R, Buchet JP, Quaeghebeur L, Cornu ME, Phillips SC, Mutti A, Lucertini S, Franchini I. A cross-sectional survey of kidney function in refinery employees. Amer J Industr Med 1987; 11: 177-187.
  117. Wilson CB, Dixon FJ. The renal response to immunological injury. In Brenner, Rector (eds.): The Kidney, 2.ed. Saunders, Philadelphia 1981, pp. 237-1350
  118. Yaqoob M, Bell GM, Percy DF, Finn R. Primary glomerulone­phritis and hydrocarbon exposure: a case-control study and literature review. Q J Med 1992;83: 409-18.
  119. Yaqoob M, Bell GM, Stevenson A, Mason H, Percy DF. Renal impairment with chronic hydrocarbon exposure. Q J Med 1993a; 86: 165-174.
  120. Yaqoob M, Stevenson A, Mason H, Bell GM. Hydrocarbon exposure and tubular damage: additional factors in the progression of renal failure in primary glomerulonephritis. QJ Med 1993b: 86: 661-7
  121. Yaqoob M, Bell GM. Occupational factors and renal disease. Renal Failure 1994a;16:425-34.
  122. Yaqoob M, Patrick AW, McClelland P, et al. Occupational hydrocarbon exposure and diabetic nephropathy. Diabetic Med 1994b; 11: 789-93
  123. Zanetti M, Druet P. Passive Heymann’s nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins. Clin Exp Immunol 1980; 41:189-195
  124. Zimmerman SW, Groehler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet, 1975; 2: 199-201.
  125. Zimmerman SW, Varanasi UR, Hoff B. Goodpasture´s syndrome with normal renal function. Am J Med 1979a; 66: 163-171.
  126. Zimmerman SW. Characterizationof chronic N,N´-diacetylbenzidine-induced nephropathy. Am J Pathol 1979b;94:285-300.
  127. Zimmerman SW, Norback DH, Powers K. Carbon tetrachloride nephrotoxicity in rats with reduced renal mass. Arch Pathol Lab Med 1983; 107: 264-9.
  128. Churchill DN, Fine A, Gault MH. Association between hydrocarbon exposure and glomerulonephritis. Nephron 1983; 33: 169-172.
  129. Rosenman KD, Moore-Fuller M, Reilly MJ. Kidney disease and silicosis. Nephron 2000; 85: 14-19.
  130. Calvert GM, Steenland K. End-stage renal disease among silica-exposed gold miners. JAMA 1997; 277: 1219-1223.
  131. Ng TP, Ng YL, Lee HS, Chia KS, Ong HY. A study of silica nephrotoxicity in exposed silicotic and non-silicotic workers. Brit J Indust Med 1992;49: 35-37.
  132. Ng TP, Lee HS, Phoon WH. Further evidence of human silica nephrotoxicity in occupationally exposed workers. Brit J Indust Med 1993; 50: 907-912.
  133. Boujemaa W, Laywerys R, Bernard A. Early indicators of renal dysfunction in silicotic workers. Scand J Environ Health 1994; 20: 180-183.
  134. Hotz P, Gonzales-Lorenzo J, Siles E, Trulillano G, Lauwerys R, Bernard A. Subclinical signs of kidney dysfunction following short exposure to silica in the absence of silicosis. Nephron 1995; 70: 438-442.
  135. Nuyts GD, van Vlem E, de Vos A et al. Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol Dial Transpl 1995; 10: 1162-1165.
  136. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999;107 Suppl 5:793-802.
  137. Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998; 10: 12-17.
  138. Floyd M. et al.A nephropathy occurring in rats treated with dinitrochlorobenzene and N-methyl-N1-nitro-N-Nitroso guanidine. Beitr Pathol 1975;155:343-356
  139. Hartmann HA, Miller EC, Miller JA. Periarteritis in rats given single injection of 4′-fluoro-10-methyl- 1,2-benzanthracene. Proc Soc Exp Biol Med 1959;101:626-629.
  140. Mensing T, Welge P, Voss B, Fels LM, Fricke HH, Bruning T, Wilhelm M. Renal toxicity after chronic inhalation exposure of rats to trichloroethylene. Toxicol Lett 2002;128:243-7.
  141. Norton WN, Mattie DR.The cytotoxic effects of trimethylpentane on rat renal tissue. Scanning Microsc 1987;1:783-1790.
  142. Ogata S, Takeda M, Lee MJ, Itagaki S, Doi K. Histopathological sequence of hepatic and renal lesions in rats after cessation of the repeated administration of CCl4. Exp Toxicol Pathol 1995;47:493-409.
  143. Nun C. L’intoxication par le trichloroethylene. Etude expérimentale et clinique. Université de Bordeaux 1938.
  144. Lande P, Dervillée P, Nun C. Recherches expérimentalessur l’action toxique du trichloréthylène. Arch Malad Profess 1939;2:454-463.
  145. Harman JW, Miller EC, Miller JA. Chronic glomerulonephritis and nephrotic syndrome induced in rats byN-N´-diacetylbenzidine. Am J Pathol 1952;28:529-30.
  146. Ravnskov U. Experimental glomerulonephritis induced by hydrocarbon exposure. A systematic review. BMCN Nephrol 2005;6:15-18
  147. Ravnskov U. The crucial role of tubulotoxic cheicals in renal failure. OA Nephrology 2013;1:14-17